患者第一:在患有急性淋巴细胞白血病的年轻成年人中导航阿斯巴拉基纳基治疗
Ryan D Cassaday1,2, Daniel J DeAngelo3,4
1Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, Washington, USA.
American journal of hematology
|January 14, 2026
概括
本指南为患有急性淋巴细胞白血病 (ALL) 的年轻成年人成功治疗阿斯巴拉金酶提供了实用策略. 它专注于优化治疗,管理毒性,并解决独特的患者需求以改善结果.
科学领域:
- 血液学 / 瘤学
- 临床实践 临床实践
背景情况:
- 年轻人的急性淋巴细胞白血病 (ALL) 面临着独特的挑战.
- 基于阿斯巴拉金酶的治疗非常重要,但与毒性有关.
研究的目的:
- 为临床医生提供实用策略,以阿斯巴拉基纳酶为基础的治疗年轻成人ALL.
- 通过优化治疗和以患者为中心的护理来改善结果.
主要方法:
- 基于案例的方法整合了患者的故事,证据和指南.
- 专注于治疗药物监测和毒性管理.
- 解决系统层面和心理社会障碍.
主要成果:
- 关于减轻,监测和管理与阿斯巴拉基纳相关的毒性方面的指导.
- 检测过敏和及时替代阿斯巴拉基纳的建议.
- 应对ALL年轻成年人的心理社会挑战的策略.
结论:
- 优化阿斯巴拉基纳斯的使用和综合护理可以改善ALL的年轻成年人的结果.
- 管理毒性和心理社会因素是成功治疗的关键.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


